Lantheus Holdings (LNTH) Cash from Investing Activities (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Cash from Investing Activities came in at -$2.0 million in Q2 2026, up 99.13% year-over-year from -$1.0 million in Q2 2025, and down 107.78% quarter-over-quarter from $26.0 million in Q1 2026.
Analysis
Lantheus Holdings (LNTH) Cash from Investing Activities (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Cash from Investing Activities for 13 consecutive years, with -$2.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Investing Activities rose 99.13% year-over-year to -$2.0 million in Q2 2026; TTM through Jun 2026 was -$307.0 million, a 17.16% increase from a year earlier, with the FY2025 full-year figure at -$627.2 million, down 177.49% from the prior year.
- Cash from Investing Activities was -$2.0 million for Q2 2026 at Lantheus Holdings, down from $26.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $83.2 million in Q3 2023 and troughed at -$319.5 million in Q3 2025.
- A 5-year average of -$61.1 million and a median of -$16.4 million in 2023 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities tumbled 5725.79% in 2022 and soared 1466.47% in 2023, its largest moves.
- Over 5 years, Cash from Investing Activities stood at -$264.7 million in 2022, then surged by 95.44% to -$12.1 million in 2023, then surged by 45.3% to -$6.6 million in 2024, then plunged by 74.34% to -$11.5 million in 2025, then surged by 82.42% to -$2.0 million in 2026.
- The last three Cash from Investing Activities figures came in at -$2.0 million (Q2 2026), $26.0 million (Q1 2026), and -$11.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | -115.00 Mn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | -2.02 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | -4.00 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | -974,000.00 |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | -606,000.00 |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | -6.30 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | -107.30 Mn |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn | 41.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.02 Mn |
| Mar 31, 2026 | 25.99 Mn |
| Dec 31, 2025 | -11.51 Mn |
| Sep 30, 2025 | -319.47 Mn |
| Jun 30, 2025 | -232.47 Mn |
| Mar 31, 2025 | -63.72 Mn |
| Dec 31, 2024 | -6.60 Mn |
| Sep 30, 2024 | -67.80 Mn |
| Jun 30, 2024 | -45.09 Mn |
| Mar 31, 2024 | -106.53 Mn |
| Dec 31, 2023 | -12.07 Mn |
| Sep 30, 2023 | 83.22 Mn |
| Jun 30, 2023 | -20.70 Mn |
| Mar 31, 2023 | -44.51 Mn |
| Dec 31, 2022 | -264.72 Mn |
| Sep 30, 2022 | -6.09 Mn |
| Jun 30, 2022 | -4.34 Mn |
| Mar 31, 2022 | -1.39 Mn |
| Dec 31, 2021 | -4.54 Mn |
| Sep 30, 2021 | -2.42 Mn |